Cidara Therapeutics EBITDA Margin (Quarterly) Trends

Cidara Therapeutics, Inc. (CDTX)

221.38 0.00 (0.00%) USD | NASDAQ | Feb 19, 16:00

EBITDA Margin (Quarterly) Chart

View EBITDA Margin (Quarterly) for CDTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBITDA Margin (Quarterly) Chart

Start Trial

Historical Data

View Historical Data

Start Trial

EBITDA Margin Definition

View EBITDA Margin Definition

Start Trial

EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.

Read full definition.

EBITDA Margin (Quarterly) Range, Past 5 Years

View EBITDA Margin (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

EBITDA Margin (Quarterly) Benchmarks

View EBITDA Margin (Quarterly) Benchmarks

Start Trial

Merck & Co., Inc.	Upgrade
Cogent Biosciences, Inc.	--
Olema Pharmaceuticals, Inc.	--
Rhythm Pharmaceuticals, Inc.	Upgrade
BridgeBio Pharma, Inc.	Upgrade